< Back to Article

Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis

Table 2

Model parameters.

Base case model parameters, upper and lower bounds for deterministic sensitivity analysis and distribution parameters for probabilistic sensitivity analysis.

doi: https://doi.org/10.1371/journal.pone.0226754.t002